Walgreens Concludes 125-Year Public Market Chapter with $10 Billion Take-Private Deal

The landmark acquisition of pharmacy giant Walgreens by private equity firm Sycamore Partners has officially closed, marking the end of the company’s nearly 125-year tenure on public markets. The deal, valued at approximately $10 billion, was finalized yesterday, resulting in the delisting of Walgreens stock from the Nasdaq at a price of $11.45 per share.

Under its new ownership, Walgreens will undergo a significant operational overhaul. Sycamore Partners plans to separate the corporation into five distinct, independent entities: Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD. This strategic move is designed to allow each business unit to sharpen its focus on its specific core market and operational strengths.

This new phase will be led by CEO Mike Motz, Read more...